• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度甲型和乙型血友病中的凝血酶生成:富血小板血浆中的内源性凝血酶潜力

Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.

作者信息

Siegemund Thomas, Petros Sirak, Siegemund Annelie, Scholz Ute, Engelmann Lothar

机构信息

Clinical Haemostaseology, Medical Clinic I, University of Leipzig, Leipzig, Germany.

出版信息

Thromb Haemost. 2003 Nov;90(5):781-6. doi: 10.1160/TH03-01-0027.

DOI:10.1160/TH03-01-0027
PMID:14597971
Abstract

Thrombin generation was investigated in platelet-rich plasma (PRP) from 11 healthy controls, 17 patients with severe haemophilia A and 7 patients with severe haemophilia B. Mean endogenous thrombin potential (ETP) in arbitrary fluorescence units (FU) was 226.9 +/- 44.6, 186.4 +/- 22.5, 154.2 +/- 41.3 in controls, haemophilia A and B, respectively, all at a platelet count of 200 x 10(9)/l (p = 0.004 for controls vs. haemophilia A, p = 0.003 for controls vs. haemophilia B, no significant difference between haemophilia A and B). The contribution of FVIII to thrombin generation in haemophilia A was 1.31 +/- 0.16 FU/% of FVIII:C activity, while for FIX in haemophilia B this was 0.80 +/- 0.21 FU/% of FIX activity. There was an almost linear relationship between increasing platelet count and thrombin generation up to a mean platelet count of 100 x 10(9)/l. Further increase in platelet count has only a marginal influence on thrombin generation. Platelets increase ETP in haemophilia A by 0.184 +/- 0.022 FU/10(9) platelets/l and in haemophilia B by 0.319 +/- 0.085 FU/10(9) platelets/l, and this was significantly different between the two groups (p = 0.0002). This influence of plate-lets diminishes with increasing concentration of either FVIII or FIX. In conclusion, there is a difference in thrombin generation between haemophilia A and B, and this may be attributed to the role of platelets in the assembly of the tenase complex on their surface.

摘要

对11名健康对照者、17名重度甲型血友病患者和7名重度乙型血友病患者的富血小板血浆(PRP)中的凝血酶生成情况进行了研究。以任意荧光单位(FU)表示的平均内源性凝血酶潜力(ETP)在对照者、甲型血友病患者和乙型血友病患者中分别为226.9±44.6、186.4±22.5、154.2±41.3,所有样本的血小板计数均为200×10⁹/L(对照者与甲型血友病患者相比,p = 0.004;对照者与乙型血友病患者相比,p = 0.003;甲型血友病患者与乙型血友病患者之间无显著差异)。在甲型血友病中,FVIII对凝血酶生成的贡献为1.31±0.16 FU/ FVIII:C活性的百分比,而在乙型血友病中,FIX的这一贡献为0.80±0.21 FU/ FIX活性的百分比。在平均血小板计数达到100×10⁹/L之前,血小板计数增加与凝血酶生成之间几乎呈线性关系。血小板计数进一步增加对凝血酶生成的影响很小。血小板使甲型血友病患者的ETP增加0.184±0.022 FU/10⁹血小板/L,使乙型血友病患者的ETP增加0.319±0.085 FU/10⁹血小板/L,两组之间存在显著差异(p = 0.0002)。随着FVIII或FIX浓度的增加,血小板的这种影响会减弱。总之,甲型血友病和乙型血友病在凝血酶生成方面存在差异,这可能归因于血小板在其表面组装凝血酶原酶复合物中的作用。

相似文献

1
Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.重度甲型和乙型血友病中的凝血酶生成:富血小板血浆中的内源性凝血酶潜力
Thromb Haemost. 2003 Nov;90(5):781-6. doi: 10.1160/TH03-01-0027.
2
Platelets significantly modify procoagulant activities in haemophilia A.血小板可显著改变血友病 A 患者的促凝活性。
Haemophilia. 2011 Sep;17(5):743-51. doi: 10.1111/j.1365-2516.2011.02601.x. Epub 2011 Jun 20.
3
Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.对甲型和乙型血友病患者血浆中凝血酶生成能力的评估。
Thromb Haemost. 2005 Mar;93(3):475-80. doi: 10.1160/TH04-10-0706.
4
Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.重度甲型血友病患者输注凝血因子 VIII 后的全血止血功能测定
Br J Haematol. 2007 Sep;138(6):775-82. doi: 10.1111/j.1365-2141.2007.06722.x. Epub 2007 Aug 2.
5
Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.血友病 A 患者中导致因子 VIII 检测结果差异的突变与凝血酶生成。
Haemophilia. 2010 Jul 1;16(4):671-4. doi: 10.1111/j.1365-2516.2009.02190.x. Epub 2010 Feb 9.
6
Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.在模拟血友病条件的重建细胞模型中,rFVIIa(诺维赞)和 NN1731 诱导的凝血酶生成和血小板活化。
Haemophilia. 2009 Nov;15(6):1318-26. doi: 10.1111/j.1365-2516.2009.02073.x. Epub 2009 Jul 29.
7
Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.重度血友病患者不存在代偿性血小板激活,但有证据表明存在血小板胶原激活缺陷。
Platelets. 2002 Dec;13(8):451-8. doi: 10.1080/0953710021000059422.
8
Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma.评估血友病中的凝血酶生成试验:新鲜和冷冻富血小板血浆的比较研究。
Haemophilia. 2013 Mar;19(2):318-21. doi: 10.1111/hae.12044. Epub 2012 Nov 23.
9
Concizumab, an anti-tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay.康西昔布,一种抗组织因子途径抑制剂抗体,通过血栓生成试验测量,可诱导血友病患者和健康受试者血浆中凝血酶生成增加。
Haemophilia. 2017 Sep;23(5):769-776. doi: 10.1111/hae.13260. Epub 2017 Jun 8.
10
Thrombin generation and phenotypic correlation in haemophilia A.甲型血友病中的凝血酶生成与表型相关性
Haemophilia. 2005 Jul;11(4):326-34. doi: 10.1111/j.1365-2516.2005.01107.x.

引用本文的文献

1
Prevalence of non-Alcoholic Fatty Liver Disease and Associated Factors in Patients with Moderate or Severe Hemophilia: A Multicenter-Based Study.非酒精性脂肪性肝病在中重度血友病患者中的流行情况及其相关因素:一项基于多中心的研究。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221128294. doi: 10.1177/10760296221128294.
2
Effect on haemostasis of different replacement fluids during therapeutic plasma exchange-A comparative multicentre observational study.不同置换液在治疗性血浆置换中对止血功能的影响:一项比较多中心观察性研究。
J Clin Apher. 2022 Dec;37(6):534-543. doi: 10.1002/jca.22008. Epub 2022 Aug 24.
3
The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs.
校准自动化血栓图在新生儿中的作用:描述新生儿止血机制和评估止血药物。
Eur J Pediatr. 2022 Jan;181(1):23-33. doi: 10.1007/s00431-021-04196-8. Epub 2021 Jul 20.
4
ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.使用STG-BleedScreen、STG-DrugScreen和STG-ThromboScreen试剂对117名健康献血者进行检测所得的ST Genesia参考值。
Res Pract Thromb Haemost. 2020 Dec 19;5(1):187-196. doi: 10.1002/rth2.12455. eCollection 2021 Jan.
5
Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets.血小板存在时凝血酶生成的临床应用、陷阱及不确定性
J Clin Med. 2019 Dec 30;9(1):92. doi: 10.3390/jcm9010092.
6
Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.凝血因子XII基因变异、体外凝血酶生成与老年人中风风险:心血管健康研究结果
J Thromb Haemost. 2015 Oct;13(10):1867-77. doi: 10.1111/jth.13111. Epub 2015 Sep 14.
7
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?库欣综合征中的凝血酶生成:传统凝血指标能完全反映实际情况吗?
Pituitary. 2014 Feb;17(1):68-75. doi: 10.1007/s11102-013-0467-3.
8
Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.抗血小板药物可促进富含血小板血浆中的双峰凝血酶生成:机制与可能的应用。
PLoS One. 2013;8(2):e55688. doi: 10.1371/journal.pone.0055688. Epub 2013 Feb 6.
9
From principle to practice: bridging the gap in patient profiling.从原则到实践:缩小患者分析的差距。
PLoS One. 2013;8(1):e54728. doi: 10.1371/journal.pone.0054728. Epub 2013 Jan 25.
10
A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.改良的凝血酶原生成试验用于检测血友病 A 中极低水平的因子 VIII 活性。
Int J Hematol. 2009 Dec;90(5):576-582. doi: 10.1007/s12185-009-0450-y. Epub 2009 Nov 25.